New therapies for the failing heart: Trans-genes versus trans-cells

Translational Research

Volumn 156, Issue 3, 2010, Pages 130-135

  Lionetti, Vincenzo ^a,b   Recchia, Fabio A ^a,b,c  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL THERAPY; CELL REGENERATION; GENE THERAPY; HEART FAILURE; HUMAN; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TRANSGENE; CELL TRANSPLANTATION; GENE TRANSFER; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; TRANSPLANTATION;

CELL TRANSPLANTATION; CELL- AND TISSUE-BASED THERAPY; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEART FAILURE; HUMANS; PLURIPOTENT STEM CELLS; REGENERATION; STEM CELL TRANSPLANTATION; TRANSGENES;

EID: 77956255005     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.06.009     Document Type: Review

References (47)

1. M. Packer The impossible task of developing a new treatment for heart failure J Card Fail 8 2002 193 196
2. M.R. Capecchi High efficiency transformation by direct microinjection of DNA into cultured mammalian cells Cell 22 1980 479 488
3. D.A. Miller, D.J. Jolly, T. Friedmann, and I.M. Verma A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT Proc Natl Acad Sci U S A 80 1983 4709 4713
4. A.D. Miller, R.J. Eckner, D.J. Jolly, T. Friedmann, and I.M. Verma Expression of a retrovirus encoding human HPRT in mice Science 225 1984 630 632
5. H. Lin, M.S. Parmacek, G. Morle, S. Bolling, and J.M. Leiden Expression of recombinant genes in myocardium in vivo after direct injection of DNA Circulation 82 1990 2217 2221
6. D.J. Stewart, J.D. Hilton, and J.M. Arnold Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment Gene Ther 13 2006 1503 1511
7. Z.J. Yang, S.L. Xu, and B. Chen Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease Clin Exp Pharmacol Physiol 36 2009 790 796
8. D.J. Stewart, M.J. Kutryk, and D. Fitchett VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial Mol Ther 17 2009 1109 1115
9. K.A. Jackson, S.M. Majka, and H. Wang Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells J Clin Invest 107 2001 1395 1402
10. A.A. Kocher, M.D. Schuster, and M.J. Szaboles Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function Nat Med 7 2001 430 436
11. P. Menasche, A.A. Hagege, and M. Scorsin Myoblast transplantation for heart failure Lancet 357 2001 279 280
12. D. Orlic, J. Kajstura, and S. Chimenti Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
13. P.D. Yoon, R.L. Kao, and G.J. Magovern Myocardial regeneration. Transplanting satellite cells into damaged myocardium Tex Heart Inst J 22 1995 119 125
14. R.E. Bittner, C. Schöfer, and K. Weipoltshammer Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice Anat Embryol 199 1999 391 396
15. S. Tomita, R.K. Li, and R.D. Weisel Autologous transplantation of bone marrow cells improves damaged heart function Circulation 100 1999 II247 II256
16. K.W. Liechty, T.C. MacKenzie, and A.F. Shaaban Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep Nat Med 6 2000 1282 1286
17. H. Reinecke, E. Minami, W.Z. Zhu, and M.A. Laflamme Cardiogenic differentiation and transdifferentiation of progenitor cells Circ Res 103 2008 1058 1071
18. M.F. Piepoli Transplantation of progenitor cells and regeneration of damaged myocardium: more facts or doubts? Insights from experimental and clinical studies J Cardiovasc Med 10 2009 624 634
19. E. Martin-Rendon, S. Brunskill, and C. Doree Stem cell treatment for acute myocardial infarction Cochrane Database Syst Rev 2008 CD006536
20. S.N. Zhang, A.J. Sun, and J.B. Ge Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: A meta-analysis of randomised controlled trials Int J Cardiol 136 2009 178 185
21. V. Schächinger, B. Assmus, and S. Erbs Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial Eur J Heart Fail 11 2009 973 979
22. C.E. Murry, M.H. Soonpaa, H. Reinecke, and H. Schleyer Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 654 668
23. P. Menasché, O. Alfieri, and S. Janssens The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
24. R.R. Smith, L. Barile, and H.C. Cho Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens Circulation 115 2007 896 908
25. X.L. Tang, G. Rokosh, and S.K. Sanganalmath Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction Circulation 121 2010 293 305
26. J.M. Hare, J.H. Traverse, and T.D. Henry A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
27. R. Madonna, and R. De Caterina Adipose tissue: a new source for cardiovascular repair J Cardiovasc Med 11 2010 71 80
28. C. Ventura, S. Cantoni, and F. Bianchi Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts J Biol Chem 282 2007 14243 14252
29. L.E. Vinge, P.W. Raake, and W.J. Koch Gene therapy in heart failure Circ Res 102 2008 1458 1470
30. M.J. Byrne, J.M. Power, A. Preovolos, J.A. Mariani, R.J. Hajjar, and D.M. Kaye Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals Gene Ther 15 2008 1550 1557
31. K. Wittköpper, L. Fabritz, and S. Neef Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging J Clin Invest 120 2010 617 626
32. Q. Liu, X. Chen, and S.M. Macdonnell Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach Circ Res 105 2009 194 200
33. B.E. Jaski, M.L. Jessup, and D.M. Mancini Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181
34. A.A. Mangi, N. Noiseux, and D. Kong Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat Med 9 2003 1195 1201
35. R. Matsumoto, T. Omura, and M. Yoshiyama Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction Arterioscler Thromb Vasc Biol 25 2005 1168 1173
36. N.P. van Til, M. Stok, and F.S. Aerts Kaya Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype Blood 115 2010 5329 5337
37. M. Gnecchi, Z. Zhang, A. Ni, and V.J. Dzau Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 2008 1204 1219
38. J.S. Burchfield, and S. Dimmeler Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis Fibrogenesis Tissue Repair 1 2008 4
39. M. Ferrarini, N. Arsic, and F.A. Recchia Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs Circ Res 98 2006 954 961
40. L. Zentilin, U. Puligadda, and V. Lionetti Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction FASEB J 24 2010 1467 1478
41. M. Pepe, M. Mamdani, and L. Zentilin Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy Circ Res 106 2010 1893 1903
42. M.J. Everly Cardiac transplantation in the United States: an analysis of the UNOS registry Clin Transpl 2008 35 43
43. S. Gupta, R. Maitra, D. Young, A. Gupta, and S. Sen Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy Am J Physiol Heart Circ Physiol 297 2009 H627 H636
44. L. Suckau, H. Fechner, and E. Chemaly Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy Circulation 119 2009 1241 1252
45. Y. Ye, Z. Hu, Y. Lin, C. Zhang, and J.R. Perez-Polo Downregulation of microRNA-29 by antisense inhibitors and a PPAR-{gamma} agonist protects against myocardial ischaemia-reperfusion injury Cardiovasc Res 2010 Mar 13 [Epub ahead of print]
46. J. Leor, S. Tuvia, and V. Guetta Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine J Am Coll Cardiol 54 2009 1014 1023
47. V. Lionetti, S. Cantoni, and C. Cavallini Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation J Biol Chem 285 2010 9949 9961